Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
R&D
Fierce Biotech
ADC Therapeutics shutters UK R&D site, lays off 30% of staff
The company is closing a U.K. R&D facility and laying off a third of its global workforce, an effort that is expected to be complete by Sept. 30.
Gabrielle Masson
Jun 12, 2025 3:00pm
Teva forecasts $5B-plus in innovative drug sales by 2030
May 30, 2025 7:20am
Pfizer cranks up overall savings target to $7.7B
Apr 29, 2025 11:18am
Roche to swell US footprint with sweeping $50B investment
Apr 22, 2025 11:10am
Biogen blueprints headquarters move to new digs in Cambridge
Mar 24, 2025 10:15am
Amid ongoing launches, Novo eyes rare disease leadership
Mar 7, 2025 9:20am
